151 related articles for article (PubMed ID: 9650802)
1. Improvement by FUB 181, a novel histamine H3-receptor antagonist, of learning and memory in the elevated plus-maze test in mice.
Onodera K; Miyazaki S; Imaizumi M; Stark H; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):508-13. PubMed ID: 9650802
[TBL] [Abstract][Full Text] [Related]
2. Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice.
Miyazaki S; Imaizumi M; Onodera K
Life Sci; 1995; 57(23):2137-44. PubMed ID: 7475966
[TBL] [Abstract][Full Text] [Related]
3. Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice.
Miyazaki S; Onodera K; Imaizumi M; Timmerman H
Life Sci; 1997; 61(4):355-61. PubMed ID: 9244361
[TBL] [Abstract][Full Text] [Related]
4. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
Stark H; Hüls A; Ligneau X; Purand K; Pertz H; Arrang JM; Schwartz JC; Schunack W
Arch Pharm (Weinheim); 1998 Jun; 331(6):211-8. PubMed ID: 9713254
[TBL] [Abstract][Full Text] [Related]
5. Effects of thioperamide on the cholinergic system and the step-through passive avoidance test in mice.
Miyazaki S; Imaizumi M; Onodera K
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):653-8. PubMed ID: 9053585
[TBL] [Abstract][Full Text] [Related]
6. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.
Pérez-García C; Morales L; Cano MV; Sancho I; Alguacil LF
Psychopharmacology (Berl); 1999 Feb; 142(2):215-20. PubMed ID: 10102775
[TBL] [Abstract][Full Text] [Related]
7. Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice.
Miyazaki S; Imaizumi M; Onodera K
Life Sci; 1995; 56(19):1563-70. PubMed ID: 7723584
[TBL] [Abstract][Full Text] [Related]
8. H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways.
Blandizzi C; Colucci R; Tognetti M; De Paolis B; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):193-202. PubMed ID: 11219402
[TBL] [Abstract][Full Text] [Related]
9. Ameliorating effects of histidine on learning deficits in an elevated plus-maze test in mice and the contribution of cholinergic neuronal systems.
Miyazaki S; Imaizumi M; Onodera K
Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():57-63. PubMed ID: 8750797
[TBL] [Abstract][Full Text] [Related]
10. Effect of histamine H3-receptor antagonist clobenpropit on spatial memory of radial maze performance in rats.
Chen Z
Acta Pharmacol Sin; 2000 Oct; 21(10):905-10. PubMed ID: 11501041
[TBL] [Abstract][Full Text] [Related]
11. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
Liedtke S; Flau K; Kathmann M; Schlicker E; Stark H; Meier G; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):43-50. PubMed ID: 12616340
[TBL] [Abstract][Full Text] [Related]
12. Histamine H(3)-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two-trial place recognition task.
Orsetti M; Ghi P; Di Carlo G
Behav Brain Res; 2001 Oct; 124(2):235-42. PubMed ID: 11640976
[TBL] [Abstract][Full Text] [Related]
13. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology.
Ligneau X; Perrin D; Landais L; Camelin JC; Calmels TP; Berrebi-Bertrand I; Lecomte JM; Parmentier R; Anaclet C; Lin JS; Bertaina-Anglade V; la Rochelle CD; d'Aniello F; Rouleau A; Gbahou F; Arrang JM; Ganellin CR; Stark H; Schunack W; Schwartz JC
J Pharmacol Exp Ther; 2007 Jan; 320(1):365-75. PubMed ID: 17005916
[TBL] [Abstract][Full Text] [Related]
14. Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in mice.
Yokoyama H; Onodera K; Iinuma K; Watanabe T
Eur J Pharmacol; 1993 Mar; 234(1):129-33. PubMed ID: 8386092
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological effects of carcinine on histaminergic neurons in the brain.
Chen Z; Sakurai E; Hu W; Jin C; Kiso Y; Kato M; Watanabe T; Wei E; Yanai K
Br J Pharmacol; 2004 Nov; 143(5):573-80. PubMed ID: 15466447
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the histamine H(3) receptor-mediated increase in exploratory locomotor activity and anxiety-like behaviours in mice.
Mohsen A; Yoshikawa T; Miura Y; Nakamura T; Naganuma F; Shibuya K; Iida T; Harada R; Okamura N; Watanabe T; Yanai K
Neuropharmacology; 2014 Jun; 81():188-94. PubMed ID: 24530460
[TBL] [Abstract][Full Text] [Related]
17. Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex.
Arrang JM; Drutel G; Schwartz JC
Br J Pharmacol; 1995 Apr; 114(7):1518-22. PubMed ID: 7606356
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA
J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
Cardell LO; Edvinsson L
Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
